JPMorgan Chase & Co. Initiates Coverage on Dentsply International Inc. (XRAY)
Analysts at JPMorgan Chase & Co. assumed coverage on shares of Dentsply International Inc. (NASDAQ:XRAY) in a report issued on Thursday. The brokerage set a “neutral” rating on the stock.
Other equities analysts have also issued research reports about the company. Credit Suisse Group AG reissued a “buy” rating on shares of Dentsply International in a report on Sunday, June 26th. Piper Jaffray Cos. assumed coverage on Dentsply International in a report on Monday, June 13th. They set an “overweight” rating and a $70.00 price target on the stock. Jefferies Group reissued a “buy” rating on shares of Dentsply International in a report on Wednesday, August 17th. Barrington Research lowered Dentsply International from an “outperform” rating to a “market perform” rating in a report on Monday, August 8th. Finally, Zacks Investment Research lowered Dentsply International from a “buy” rating to a “hold” rating in a report on Monday, August 8th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $67.00.
Dentsply International (NASDAQ:XRAY) opened at 59.89 on Thursday. The firm’s 50 day moving average price is $60.83 and its 200-day moving average price is $61.57. The firm has a market cap of $13.96 billion, a PE ratio of 28.10 and a beta of 1.40. Dentsply International has a one year low of $49.48 and a one year high of $65.83.
Dentsply International (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.06. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The business’s quarterly revenue was up 46.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.73 earnings per share. Equities analysts predict that Dentsply International will post $2.76 EPS for the current fiscal year.
In other news, SVP Maureen J. Macinnis sold 45,100 shares of Dentsply International stock in a transaction that occurred on Thursday, August 25th. The shares were sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the completion of the sale, the senior vice president now directly owns 36,730 shares in the company, valued at approximately $2,224,001.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Rainer Berthan sold 5,000 shares of Dentsply International stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total transaction of $305,600.00. Following the sale, the vice president now owns 34,370 shares of the company’s stock, valued at $2,100,694.40. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.
Several large investors have recently bought and sold shares of XRAY. Nisa Investment Advisors L.L.C. increased its stake in Dentsply International by 105.8% in the first quarter. Nisa Investment Advisors L.L.C. now owns 44,942 shares of the company’s stock worth $2,770,000 after buying an additional 23,101 shares during the last quarter. Buffington Mohr McNeal increased its position in shares of Dentsply International by 63.3% in the first quarter. Buffington Mohr McNeal now owns 9,025 shares of the company’s stock valued at $556,000 after buying an additional 3,500 shares in the last quarter. Mn Services Vermogensbeheer B.V. bought a new position in shares of Dentsply International during the first quarter valued at about $326,000. Aperio Group LLC increased its position in shares of Dentsply International by 115.7% in the first quarter. Aperio Group LLC now owns 106,750 shares of the company’s stock valued at $6,579,000 after buying an additional 57,270 shares in the last quarter. Finally, Telemus Capital LLC bought a new position in shares of Dentsply International during the first quarter valued at about $482,000. Institutional investors own 94.58% of the company’s stock.
Dentsply International Company Profile
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.